Just Accepted Manuscripts
Research Articles

PFAS Toxicity and Female Reproductive Health: A Review of the Evidence and Current State of Knowledge

PDF (Just Accepted)
  • Maryjane Nnabuchi,
  • Chidi Duru
Maryjane Nnabuchi
Surface Chemistry and Environmental Technology (SCENT) Research Group, Department of Chemistry, Imo State University, Owerri, PMB 2000, Imo State, Nigeria
Bio
Chidi Duru
Surface Chemistry and Environmental Technology (SCENT) Research Group, Department of Chemistry, Imo State University, Owerri, PMB 2000, Imo State, Nigeria
Bio
DOI: https://doi.org/10.36253/Substantia-2842

Published 2024-10-31

Keywords

  • PFAS,
  • Female fertility,
  • Pregnancy,
  • Endocrine disruption,
  • Menstrual cycle

How to Cite

Nnabuchi, M., & Duru, C. (2024). PFAS Toxicity and Female Reproductive Health: A Review of the Evidence and Current State of Knowledge. Substantia. https://doi.org/10.36253/Substantia-2842

Copyright (c) 2024 Maryjane Nnabuchi, Chidi Duru

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Per- and polyfluoroalkyl substances (PFAS) constitute a class of synthetic chemicals extensively utilized in various consumer products and industrial applications. Characterized by their remarkable persistence, PFAS chemicals resist degradation, perpetuating their presence in the environment for an indefinite period. Human exposure to PFAS occurs through multiple pathways, including contaminated food, water, air, and products, resulting in widespread detection in biological matrices such as blood and urine. Exposure to PFAS has also been linked to adverse reproductive outcomes, yet the impact on female reproductive health remains poorly understood. This review synthesizes recent findings on the PFAS-female reproductive health connection, highlighting the effects on ovarian function, hormone regulation, and pregnancy outcomes. The evidence suggests that PFAS exposure is associated with reduced fertility, increased risk of miscarriage, and altered menstrual cycle dynamics. The review also explores the underlying mechanisms, including endocrine disruption and oxidative stress. The implications of these findings on female reproductive health are discussed, emphasizing the need for further research and policy changes to mitigate PFAS exposure and protect female reproductive physiology.

PDF (Just Accepted)

References

  1. Athar, F.; Karmani, M.; Templeman, N. Metabolic Hormones Are Integral Regulators of Female Reproductive Health and Function. Biosci. Rep. 2024, 31 (1), BSR20231916. https://doi.org/10.1042/BSR20231916
  2. Atiya, A.; Somia, G. Reproductive Hormones and Implication of Synthetic Hormonal Preparations: Current Status. Biomed. J. Sci. Tech. Res. 2021, 38 (2), 30156–30159.
  3. Bangma, J.; Eaves, L. A.; Oldenburg, K.; Reiner, J. L.; Manuck, T.; Fry, R. C. Identifying Risk Factors for Levels of Per- and Polyfluoroalkyl Substances (PFAS) in the Placenta in a High-Risk Pregnancy Cohort in North Carolina. Environ. Sci. Technol. 2020, 54 (13), 8158–8166.
  4. Bangma, J. J.; Szilagyi, B. E.; Blake, C.; Plazas, S.; Kepper, S. E.; Fenton, R. C. An Assessment of Serum-Dependent Impacts on Intracellular Accumulation and Genomic Response of Per- and Polyfluoroalkyl Substances in a Placental Trophoblast Model. Environ. Toxicol. 2020, 35 (12), 1395–1405.
  5. Barrett, E. S.; Chen, C.; Thurston, S. W.; Haug, L. S.; Sabaredzovic, A.; Fjeldheim, F. N.; Frydenberg, H.; Lipson, S. F.; Ellison, P. T.; Thune, I. Perfluoroalkyl Substances and Ovarian Hormone Concentrations in Naturally Cycling Women. Fertil. Steril. 2015, 103 (5), 1261–1270.
  6. Barton-Maclaren, T. S.; Wade, M.; Basu, N.; Bayen, S.; Grundy, J.; Marlatt, V.; Moore, R.; Parent, L.; Parrott, J.; Grigorova, P.; Pinsonnault-Cooper, J.; Langlois, V. S. Innovation in Regulatory Approaches for Endocrine Disrupting Chemicals: The Journey to Risk Assessment Modernization in Canada. Environ. Res. 2022, 204, 112225.
  7. Behr, A. C.; Lichtenstein, D.; Braeuning, A.; Lampen, A.; Buhrke, T. Perfluoroalkylated Substances (PFAS) Affect Neither Estrogen and Androgen Receptor Activity nor Steroidogenesis in Human Cells In Vitro. Toxicol. Lett. 2018, 291, 251–260.
  8. Berg, C.; Crone, B.; Gullett, B.; Higuchi, M.; Krause, M. J.; Lemieux, P. M.; Martin, T.; Shields, E. P.; Struble, E.; Thoma, E.; Whitehill, A. Developing Innovative Treatment Technologies for PFAS-Containing Wastes. J. Air Waste Manag. Assoc. 2022, 72 (6), 540–555.
  9. Bridger, J. R.; Thackray, C. M.; Butt, C. M.; LeBlanc, D. R.; Tokranov, A. K.; Elsie, M. Centurial Persistence of Forever Chemicals at Military Fire Training Sites. Environ. Sci. Technol. 2023, 57 (11), 8096–8106.
  10. Brunn, H.; Arnold, G.; Körner, W.; Rippen, G.; Steinhäuser, K. G.; Valentin, I. PFAS: Forever Chemicals—Persistent, Bioaccumulative, and Mobile. Reviewing the Status and the Need for Their Phase-Out and Remediation of Contaminated Sites. Environ. Sci. Eur. 2023, 35, 20. https://doi.org/10.1186/s12302-023-00721-8
  11. Campbell, S.; Raza, M.; Pollack, A. Z. Perfluoroalkyl Substances and Endometriosis in US Women in NHANES 2003–2006. Reprod. Toxicol. 2016, 65, 230–235.
  12. Chang, V. C.; Rhee, J.; Berndt, S. I.; Moore, S. C.; Freedman, N. D.; Jones, R. R.; Silverman, D. T.; Gierach, G. L.; Hofmann, J. N.; Purdue, M. P. Serum Perfluorooctane Sulfonate and Perfluorooctanoate and Risk of Postmenopausal Breast Cancer According to Hormone Receptor Status: An Analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int. J. Cancer 2023, 153 (4), 775–782.
  13. Chen, L.; Tong, C.; Huo, X.; Zhang, J.; Tian, Y. Prenatal Exposure to Perfluoroalkyl and Polyfluoroalkyl Substances and Birth Outcomes: A Longitudinal Cohort with Repeated Measurements. Chemosphere 2021, 267, 128899.
  14. Commission for Environmental Cooperation. Furthering the Understanding of the Migration of Chemicals from Consumer Products – A Study of Per- and Polyfluoroalkyl Substances (PFASs) in Clothing, Apparel, and Children’s Items; Project Report; Montreal, Canada, 2017. http://www.cec.org/files/documents/publications/11777-furthering-understanding-migration-chemicals-from-consumer-products-en.pdf
  15. Cousins, I. T.; Johansson, J. H.; Salter, M. E.; Sha, B.; Scheringer, M. Outside the Safe Operating Space of a New Planetary Boundary for Per- and Polyfluoroalkyl Substances (PFAS). Environ. Sci. Technol. 2022, 56 (16), 11172–11179.
  16. Cousins, J. T.; DeWitt, J. C.; Glüge, J.; Goldenman, G.; Herzke, D.; Lohmann, R.; Ng, C. A.; Scheringer, M.; Wang, Z. The High Persistence of PFAS Is Sufficient for Their Management as a Chemical Class. Environ. Sci. Process Impacts 2020, 22, 2307–2312.
  17. De Silva, A. O.; Armitage, J. M.; Bruton, T. A.; Dassuncao, C.; Heiger-Bernays, W.; Hu, X. C.; Kärrman, A.; Kelly, B.; Ng, C.; Robuck, A.; Sun, M.; Webster, T. F.; Sunderland, E. M. PFAS Exposure Pathways for Humans and Wildlife: A Synthesis of Current Knowledge and Key Gaps in Understanding. Environ. Toxicol. Chem. 2021, 40 (3), 631–657.
  18. Di Nisio, A.; Rocca, M. S.; Sabovic, I.; De Rocco-Ponce, M.; Corsini, C.; Guidolin, D. Perfluorooctanoic Acid Alters Progesterone Activity in Human Endometrial Cells and Induces Reproductive Alterations in Young Women. Chemosphere 2020, 242, 125208. https://pubmed.ncbi.nlm.nih.gov/31896193/
  19. Endocrine Society. Common EDCs and Where They Are Found. https://www.endocrine.org/topics/edc/what-edcs-are/common-edcs (accessed 2023).
  20. Enyoh, C. E.; Ovuoraye, P. E.; Qingyue, W.; Weiqian, W. Examining the Impact of Nanoplastics and PFAS Exposure on Immune Functions through Inhibition of Secretory Immunoglobulin A in Human Breast Milk. J. Hazard. Mater. 2023, 459, 132103. https://pubmed.ncbi.nlm.nih.gov/37527590/
  21. Ercan, O.; Tarcin, G. Overview on Endocrine Disruptors in Food and Their Effects on Infant’s Health. Global Pediatr. 2022, 2, 100019. https://www.sciencedirect.com/science/article/pii/S2667009722000136
  22. Erinc, A.; Davis, M. B.; Padmanabhan, V.; Langen, E.; Goodrich, J. M. Considering Environmental Exposures to Per- and Polyfluoroalkyl Substances (PFAS) as Risk Factors for Hypertensive Disorders of Pregnancy. Environ. Res. 2021, 197, 111113.
  23. Escobar-Morreale, H. F. Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment. Nat. Rev. Endocrinol. 2018, 14 (5), 270–284.
  24. Feng, X.; Wang, X.; Cao, X.; Xia, Y.; Zhou, R.; Chen, L. Chronic Exposure of Female Mice to an Environmental Level of Perfluorooctane Sulfonate Suppresses Estrogen Synthesis Through Reduced Histone H3K14 Acetylation of the StAR Promoter Leading to Deficits in Follicular Development and Ovulation. Toxicol. Sci. 2015, 148 (2), 368–379.
  25. Fenton, S. E.; Ducatman, A.; Boobis, A.; DeWitt, J. C.; Lau, C.; Ng, C.; Smith, J. S.; Roberts, S. M. Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research. Environ. Toxicol. Chem. 2021, 40 (3), 606–630.
  26. Fiedler, H.; Kennedy, T.; Henry, B. J. A Critical Review of a Recommended Analytical and Classification Approach for Organic Fluorinated Compounds with an Emphasis on Per- and Polyfluoroalkyl Substances. Integr Environ. Assess. Manag. 2021, 17 (2), 331–351.
  27. Forsthuber, M.; Kaiser, A. M.; Granitzer, S. H.; Hengstschläger, M.; Stangl, H.; Gundacker, C. Albumin Is the Major Carrier Protein for PFOS, PFOA, PFHxS, PFNA, and PFDA in Human Plasma. Environ. Int. 2020, 137, 105324.
  28. Frigerio, G.; Ferrari, C. M.; Fustinoni, S. Prenatal and Childhood Exposure to Per-/Polyfluoroalkyl Substances (PFASs) and Its Associations with Childhood Overweight and/or Obesity: A Systematic Review with Meta-Analyses. Environ. Health 2023, 22 (1), 56.
  29. Gaines, L. G. T. Historical and Current Usage of Per- and Polyfluoroalkyl Substances (PFAS): A Literature Review. Am. J. Ind. Med. 2022, 66 (5), 353–378.
  30. Gao, X.; Ni, W.; Zhu, S.; Wu, Y.; Cui, Y.; Ma, J.; Liu, Y.; Qiao, J.; Ye, Y.; Yang, P.; Liu, C.; Zeng, F. Per- and Polyfluoroalkyl Substances Exposure during Pregnancy and Adverse Pregnancy and Birth Outcomes: A Systematic Review and Meta-Analysis. Environ. Res. 2021, 201, 111632. https://doi.org/10.1016/j.envres.2021.111632
  31. Glüge, J.; Scheringer, M.; Cousins, I. T.; DeWitt, J. C.; Goldenman, G.; Herzke, D.; Lohmann, R.; Ng, C. A.; Trier, X.; Wang, Z. An Overview of the Uses of Per- and Polyfluoroalkyl Substances (PFAS). Environ. Sci. Process Impacts 2021, 22 (12), 2345.
  32. González-Comadran, M.; Jacquemin, B.; Cirach, M.; Lafuente, R.; Cole-Hunter, T.; Nieuwenhuijsen, M.; Brassesco, M.; Coroleu, B.; Checa, M. A. The Effect of Short-Term Exposure to Outdoor Air Pollution on Fertility. Reprod. Biol. Endocrinol. 2021, 19 (1), 151. https://doi.org/10.1186/s12958-021-00838-6
  33. Green, M. P.; Harvey, A. J.; Finger, B. J.; Tarulli, G. A. Endocrine Disrupting Chemicals: Impacts on Human Fertility and Fecundity during the Peri-Conception Period. Environ. Res. 2021, 194, 110694. https://pubmed.ncbi.nlm.nih.gov/33385395/
  34. Grgas, D.; Petrina, A.; Štefanac, T.; Bešlo, D.; Landeka Dragičević, T. A Review: Per- and Polyfluoroalkyl Substances—Biological Degradation. Toxics 2023, 11 (5), 446.
  35. Hammarstrand, S.; Jakobsson, K.; Andersson, E.; Xu, Y.; Li, Y.; Olovsson, M.; Andersson, E. M. Perfluoroalkyl Substances (PFAS) in Drinking Water and Risk for Polycystic Ovarian Syndrome, Uterine Leiomyoma, and Endometriosis: A Swedish Cohort Study. Environ. Int. 2021, 157, 106819. https://doi.org/10.1016/j.envint.2021.106819
  36. Heffernan, A. L.; Cunningham, T. K.; Drage, D. S.; Aylward, L. L.; Thompson, K.; Vijayasarathy, S.; Mueller, J. F.; Atkin, S. L.; Sathyapalan, T. Perfluorinated Alkyl Acids in the Serum and Follicular Fluid of UK Women with and without Polycystic Ovarian Syndrome Undergoing Fertility Treatment and Associations with Hormonal and Metabolic Parameters. Int. J. Hyg. Environ. Health 2018, 221 (7), 1068–1075.
  37. Huang, M. C.; Robinson, V. G.; Waidyanatha, S.; Dzierlenga, A. L.; DeVito, M. J.; Eifrid, M. A.; Gibbs, S. T.; Blystone, C. R. Toxicokinetics of 8:2 Fluorotelomer Alcohol (8:2-FTOH) in Male and Female Hsd:Sprague Dawley SD Rats after Intravenous and Gavage Administration. Toxicol. Rep. 2019, 6, 924–932.
  38. Innocent, T. M. Bioaccumulation of Emerging Micro Pollutants in Aquatic Biota Per- and Polyfluoroalkyl Substances; Donghua University: Shanghai, China, 2022. https://www.researchgate.net/publication/362668596
  39. Interstate Technology and Regulatory Council (ITRC). Naming Conventions and Physical and Chemical Properties of Per- and Polyfluoroalkyl Substances (PFAS); 2020. https://pfas-1.itrcweb.org/fact-sheets
  40. IPEN. Stockholm Convention COP-9 White Paper: The Global PFAS Problem: Fluorine-Free Alternatives As Solutions; 2019. https://ipen.org/sites/default/files/documents/the_global_pfas_problem-v1_5_final_18_april.pdf
  41. Jørgensen, K. T.; Specht, I. O.; Lenters, V.; Bach, C. C.; Rylander, L.; Jönsson, B. A.; Lindh, C. H.; Giwercman, A.; Heederik, D.; Toft, G.; Bonde, J. P. Perfluoroalkyl Substances and Time to Pregnancy in Couples from Greenland, Poland and Ukraine. Environ. Health 2014, 13, 116. https://doi.org/10.1186/1476-069X-13-116
  42. Kang, J. S.; Choi, J. S.; Park, J. W. Transcriptional Changes in Steroidogenesis by Perfluoroalkyl Acids (PFOA and PFOS) Regulate the Synthesis of Sex Hormones in H295R Cells. Chemosphere 2016, 155, 436–443.
  43. Kang, Q.; Gao, F.; Zhang, X.; Wang, L.; Liu, J.; Fu, M.; Zhang, S.; Wan, Y.; Shen, H.; Hu, J. Nontargeted Identification of Per- and Polyfluoroalkyl Substances in Human Follicular Fluid and Their Blood-Follicle Transfer. Environ. Int. 2020, 139, 105686. https://www.sciencedirect.com/science/article/pii/S0160412019347439
  44. Kashino, I.; Sasaki, S.; Okada, E.; Matsuura, H.; Goudarzi, H.; Miyashita, C. Prenatal Exposure to Perfluoroalkyl Substances and Fetal Growth: A Large-Scale Prospective Birth Cohort Study. Environ. Int. 2020, 136, 105355. https://pubmed.ncbi.nlm.nih.gov/32029284/
  45. Kato, H.; Fujii, S.; Takahashi, M.; Matsumoto, M.; Hirata-Koizumi, M.; Ono, A.; Hirose, A. Repeated Dose and Reproductive/Developmental Toxicity of Perfluorododecanoic Acid in Rats. Environ. Toxicol. 2015, 30, 1244–1263.
  46. Khazaee, M.; Christie, E.; Cheng, W.; Michalsen, M.; Field, J.; Ng, C. Perfluoroalkyl Acid Binding with Peroxisome Proliferator-Activated Receptors alpha, gamma, and delta, and Fatty Acid Binding Proteins by Equilibrium Dialysis with a Comparison of Methods. Toxics 2021, 9 (1), 1–15.
  47. Kim, D. H.; Kim, U. J.; Kim, H. Y.; Choi, S. D.; Oh, J. E. Perfluoroalkyl Substances in Serum from South Korean Infants with Congenital Hypothyroidism and Healthy Infants—Its Relationship with Thyroid Hormones. Environ. Res. 2016, 147, 399–404.
  48. Kim, Y.; Pacella, R.; Harden, F.; White, N.; Toms, L. A Systematic Review: Impact of Endocrine Disrupting Chemicals Exposure on Fecundity as Measured by Time to Pregnancy. Environ. Res. 2019, 171, 119–133.
  49. Kim, Y. R.; White, N.; Bräunig, J.; Vijayasarathy, S.; Mueller, J. F.; Knox, C. L.; Harden, F. A.; Pacella, R.; Toms, L. L. Per- and Poly-Fluoroalkyl Substances (PFASs) in Follicular Fluid from Women Experiencing Infertility in Australia. Environ. Res. 2020, 190, 109963.
  50. Knox, S. S.; Jackson, T.; Javins, B.; Frisbee, S. J.; Shankar, A.; Ducatman, A. M. Implications of Early Menopause in Women Exposed to Perfluorocarbons. J. Clin. Endocrinol. Metab. 2011, 96, 1747–1753.
  51. Korzeniowski, S. H.; Buck, R. C.; Newkold, R. M.; El Kassmi, A.; van Laganis, E.; Matsuoka, Y.; Dinelli, B.; Beauchet, S.; Adamsky, F.; Weilandt, K.; Soni, V. K.; Kapoor, D.; Gunasekar, P.; Malvasi, M.; Brinati, G.; Musio, S. A Critical Review of the Application of Polymer of Low Concern Regulatory Criteria to Fluoropolymers II: Fluoroplastics and Fluoroelastomers. Integr Environ. Assess. Manag. 2022, 18 (4), 4646.
  52. Kurwadkar, S.; Dane, J.; Kanel, S. R.; Nadagouda, M. N.; Cawdrey, R. W.; Ambade, B.; Struckhoff, G. C.; Wilkin, R. Per- and Polyfluoroalkyl Substances in Water and Wastewater: A Critical Review of Their Global Occurrence and Distribution. Sci. Total Environ. 2022, 809, 151003. https://doi.org/10.1016/j.scitotenv.2021.151003
  53. Lai, T. T.; Eken, Y.; Wilson, A. K. Binding of Per- and Polyfluoroalkyl Substances to the Human Pregnane X Receptor. Environ. Sci. Technol. 2020, 54 (24), 15986–15995.
  54. Lee, Y. J.; Jung, H. W.; Kim, H. Y.; Choi, Y. J.; Lee, Y. A. Early-Life Exposure to Per- and PolyFluorinated Alkyl Substances and Growth, Adiposity, and Puberty in Children: A Systematic Review. Front. Endocrinol. 2021, 9 (12), 683297.
  55. Lin, C. M.; Chen, C. W.; Chen, P. T.; Lu, T. H.; Li, C. Y. Risks and Causes of Mortality among Low-Birthweight Infants in Childhood and Adolescence. Paediatr. Perinat. Epidemiol. 2007, 21 (5), 465–472.
  56. Lum, K. J.; Sundaram, R.; Barr, D. B.; Louis, T. A.; Buck Louis, G. M. Perfluoroalkyl Chemicals, Menstrual Cycle Length, and Fecundity: Findings from a Prospective Pregnancy Study. Epidemiology 2017, 28 (1), 90–98.
  57. Lyngsø, J. H.; R-HC; Høyer, B. B.; Støvring, H.; Bonde, J. P.; Jönsson, B.; Lindh, C. H.; Pedersen, H. S.; Ludwicki, J. K.; Zviezdai, V.; Toft, G. Menstrual Cycle Characteristics in Fertile Women from Greenland, Poland, and Ukraine Exposed to Perfluorinated Chemicals: A Cross-Sectional Study. Hum. Reprod. 2014, 29 (22), 359–367.
  58. Marques, P.; Skorupskaite, K.; Rozario, K. S. Physiology of GnRH and Gonadotropin Secretion; 2022. https://www.ncbi.nlm.nih.gov/books/NBK279070/
  59. Mazumder, N. U.; Hossain, M. T.; Jahura, F. T.; Girase, A.; Hall, A. S.; Lu, J.; Ormond, R. B. Firefighters' Exposure to Per- and Polyfluoroalkyl Substances (PFAS) as an Occupational Hazard: A Review. Front. Mater. 2023, 10, 1143411.
  60. McMahon, P. B.; Tokranov, A. K.; Bexfield, L. M.; Lindsey, B. D.; Johnson, T. D.; Lombard, M. A.; Watson, E. Perfluoroalkyl and Polyfluoroalkyl Substances in Groundwater Used as a Source of Drinking Water in the Eastern United States. Environ. Sci. Technol. 2022, 56 (4), 2279–2288.
  61. Meng, L.; Xiangyan, R.; Alfred, O.; Mueck. Management Strategy of Infertility in Polycystic Ovary Syndrome. Glob. Health J. 2022, 6 (2), 70–74.
  62. Minnesota’s PFAS Blueprint. Protecting families and communities from PFAS pollution. https://www.pca.state.mn.us/sites/default/files/p-gen1-22g.pdf
  63. Mueller, R.; Kate, E. S. Human and Ecological Health Effects and Risk Assessment of Per- and Polyfluoroalkyl Substances (PFAS); 2020. https://pfas-1.itrcweb.org/wp-content/uploads/2020/10/human_and_eco_health_508_20200918.pdf
  64. Neuwald, I. J.; Zahn, D.; Knepper, T. P. Are (Fluorinated) Ionic Liquids Relevant Environmental Contaminants? High-Resolution Mass Spectrometric Screening for Per- and Polyfluoroalkyl Substances in Environmental Water Samples Led to the Detection of a Fluorinated Ionic Liquid. Anal. Bioanal. Chem. 2020, 412, 4881–4892.
  65. Nian, M.; Luo, K.; Luo, F.; Aimuzi, R.; Huo, X.; Chen, Q.; Tian, Y.; Zhang, J. Association between Prenatal Exposure to PFAS and Fetal Sex Hormones: Are the Short-Chain PFAS Safer? Environ. Sci. Technol. 2020, 54, 8291–8299.
  66. Ning, D.; Siobán, D.; Harlow, J. F.; Randolph, J.; Rita, L.; Sung, K. P. Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) and Their Effects on the Ovary. Hum. Reprod. Update 2020, 26 (5), 724–752.
  67. NRDC (Natural Resources Defense Council). Engaging the Textile Industry as a Key Sector in SAICM—A Review of PFAS as a Chemical Class in the Textile Sector; 2021. https://saicmknowledge.org/sites/default/files/resources/SAICM%20report_PFAS%20in%20Textile_final_May%202021.pdf
  68. Organisation for Economic Co-operation and Development (OECD). Reconciling Terminology of the Universe of Per- and Polyfluoroalkyl Substances: Recommendations and Practical Guidance, Health and Safety Publications Series on Risk Management; 2021. www.oecd.org/chemicalsafety
  69. Padula, A. M.; Ning, X.; Bakre, S.; Barrett, E. S.; Bastain, T.; Bennett, D. H.; Bloom, M. S.; Breton, C. V.; Dunlop, A. L.; Eick, S. M.; Ferrara, A.; Fleisch, A.; Geiger, S.; Goin, D. E.; Kannan, K.; Karagas, M. R.; Korrick, S.; Meeker, J. D.; Morello-Frosch, R.; O'Connor, T. G. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program. Environ. Health Perspect. 2023, 131 (3), 37006. https://doi.org/10.1289/EHP10723
  70. PAN Europe. Europe's Toxic Harvest - Unmasking PFAS Pesticides Authorized in Europe; 2023. https://www.pan-europe.info/sites/pan-europe.info/files/public/resources/reports/PFAS%20Pesticides%20report%20November%202023.pdf
  71. Pan, Y. Worldwide Distribution of Novel Perfluoroether Carboxylic and Sulfonic Acids in Surface Water. Environ. Sci. Technol. 2018, 52 (14), 7621–7629.
  72. Pearce, J. L.; Neelon, B.; Bloom, M. S.; Buckley, J. P.; Ananth, C. V.; Perera, F. Exploring Associations between Prenatal Exposure to Multiple Endocrine Disruptors and Birthweight with Exposure Mapping. Environ. Res. 2021, 200, 111386.
  73. Peritore, A. F.; Gugliandolo, E.; Cuzzocrea, S.; Crupi, R.; Britti, D. Current Review of Increasing Animal Health Threat of Per- and Polyfluoroalkyl Substances (PFAS): Harms, Limitations, and Alternatives to Manage Their Toxicity. Int. J. Mol. Sci. 2023, 24 (14), 11707.
  74. Pierozan, P.; Karlsson, O. PFOS Induces Proliferation, Cell-Cycle Progression, and Malignant Phenotype in Human Breast Epithelial Cells. Arch. Toxicol. 2018, 92, 705–716.
  75. Qin, X. D.; Zhou, Y.; Bloom, M. S.; Qian, Z. M.; Geiger, S. D.; Vaughn, M. G.; Chu, C.; Li, Q.; Yang, B. Y.; Hu, L. W.; Yu, Y.; Zeng, X. W.; Dong, G. H. Prenatal Exposure to PFAS, Associations with Preterm Birth and Modification by Maternal Estrogen Levels: The Maoming Birth Study. Environ. Health Perspect. 2023, 131 (11), 117006.
  76. Rickard, B. P.; Rizvi, I.; Fenton, S. E. Per- and Poly-Fluoroalkyl Substances (PFAS) and Female Reproductive Outcomes: PFAS Elimination, Endocrine-Mediated Effects, and Disease. Toxicology 2022, 465, 153031. https://pubmed.ncbi.nlm.nih.gov/34774661/
  77. Rumph, J. T.; Stephens, V. R.; Martin, J. L.; Brown, L. K.; Thomas, P. L.; Cooley, A.; Osteen, K. G.; Bruner-Tran, K. L. Uncovering Evidence: Associations between Environmental Contaminants and Disparities in Women's Health. Int. J. Environ. Res. Public Health 2022, 19 (3), 1257. https://doi.org/10.3390/ijerph19031257
  78. Saliu, T. D.; Sauvé, S. A Review of Per- and Polyfluoroalkyl Substances in Biosolids: Geographical Distribution and Regulations. Front. Environ. Chem. 2024, 5, 1383185.
  79. Säve-Söderbergh, M.; Gyllenhammar, I.; Schillemans, T.; Lindfeldt, E.; Vogs, C.; Donat-Vargas, C.; Halldin Ankarberg, E.; Glynn, A.; Ahrens, L.; Helte, E.; Åkesson, A. Per- and Polyfluoroalkyl Substances (PFAS) and Fetal Growth: A Nation-Wide Register-Based Study on PFAS in Drinking Water. Environ. Int. 2024, 187, 108727. https://doi.org/10.1016/j.envint.2024.108727
  80. Schlummer, M.; Gruber, L.; Fiedler, D.; Kizlauskas, M.; Müller, J. Detection of Fluorotelomer Alcohols in Indoor Environments and Their Relevance for Human Exposure. Environ. Int. 2013, 57–58, 42–49.
  81. Shen, J.; Mao, Y.; Zhang, H.; Lou, H.; Zhang, L.; Moreira, J. P.; Jin, F. Exposure of Women Undergoing In-Vitro Fertilization to Per- and Polyfluoroalkyl Substances: Evidence on Negative Effects on Fertilization and High-Quality Embryos. Environ. Pollut. 2024, 359, 124474. https://doi.org/10.1016/j.envpol.2024.124474
  82. Singer, A. B.; Whitworth, K. W.; Haug, L. S.; Sabaredzovic, A.; Impinen, A.; Papadopoulou, E.; Longnecker, M. P. Menstrual Cycle Characteristics as Determinants of Plasma Concentrations of Perfluoroalkyl Substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa Study). Environ. Res. 2018, 166, 178–185.
  83. Skogheim, T. S.; Villanger, G. D.; Weyde, K. V. F.; Engel, S. M.; Surén, P.; Øie, M. G.; Skogan, A. H.; Biele, G.; Zeiner, P.; Øvergaard, K. R.; Haug, L. S.; Sabaredzovic, A.; Aase, H. Prenatal Exposure to Perfluoroalkyl Substances and Associations with Symptoms of Attention-Deficit/Hyperactivity Disorder and Cognitive Functions in Preschool Children. Int. J. Hyg. Environ. Health 2020, 223 (1), 80–92.
  84. Starnes, H. M.; Rock, K. D.; Jackson, T. W.; Belcher, S. M. A Critical Review and Meta-Analysis of Impacts of Per- and Polyfluorinated Substances on the Brain and Behavior. Front. Toxicol. 2022, 4, 881584. https://doi.org/10.3389/ftox.2022.881584
  85. Straková, J.; Schneider, J.; Cingotti, N. Throwaway Packaging, Forever Chemicals: European Wide Survey of PFAS in Disposable Food Packaging and Tableware; 2021. https://www.env-health.org/wp-content/uploads/2021/05/FINAL_pfas_fcm_study_web.pdf
  86. Sudarshan, K.; Jason, D.; Sushil, R.; Kanel; Mallikarjuna, N.; Nadagouda; Ryan, W.; Cawdrey, B. A.; Garrett, C.; Struckhoff, R. W. Per- and Polyfluoroalkyl Substances in Water and Wastewater: A Critical Review of Their Global Occurrence and Distribution. Sci. Total Environ. 2022, 809 (25), 151003.
  87. Szilagyi, J. T.; Freedman, A. N.; Kepper, S. L.; Keshava, A. M.; Bangma, J. T.; Fry, R. C. Per- and Polyfluoroalkyl Substances Differentially Inhibit Placental Trophoblast Migration and Invasion In Vitro. Toxicol. Sci. 2020, 175 (2), 210–219.
  88. Travis, A. S. The Discovery and Analysis of PFAS ('Forever Chemicals') in Human Blood and Biological Materials. Substantia 2024, 8 (1), 7–24.
  89. United States Environmental Protection Agency (USEPA). Per- and Polyfluoroalkyl Substances (PFAS) in Pesticide and Other Packaging; 2022. https://www.epa.gov/pesticides/pfas-packaging#packaging
  90. Wang, Y. K.; Bashashati, A.; Anglesio, M. S.; Cochrane, D. R.; Grewal, D. S.; Ha, G.; McPherson, A.; Horlings, H. M.; Senz, J.; Prentice, L. M.; Karnezis, A. N.; Lai, D.; Aniba, M. R.; Zhang, A. W.; Shumansky, K.; Siu, C.; Wan, A.; McConechy, M. K.; Li-Chang, H.; Tone, A.; Shah, S. P. Genomic Consequences of Aberrant DNA Repair Mechanisms Stratify Ovarian Cancer Histotypes. Nat. Genet. 2017, 49 (6), 856–865.
  91. Whitehead, H. D.; Venier, M.; Wu, Y.; Eastman, E.; Urbanik, S.; Diamond, M. L.; Shalin, A.; Schwartz-Narbonne, H.; Bruton, T. A.; Blum, A.; Wang, Z.; Green, M.; Tighe, M.; Wilkinson, J. T.; McGuinness, S.; Peaslee, G. F. Fluorinated Compounds in North American Cosmetics. Environ. Sci. Technol. Lett. 2021, 8, 538–544.
  92. Wikstrom, S.; Hussein, G.; Lingroth, K. A.; Lindh, C. H.; Bornehag, C. G. Exposure to Perfluoroalkyl Substances in Early Pregnancy and Risk of Sporadic First Trimester Miscarriage. Sci. Rep. 2021, 11, 3568. https://www.nature.com/articles/s41598-021-82748-6
  93. Wikström, S.; Lin, P. I.; Lindh, C. H.; Shu, H.; Bornehag, C. G. Maternal Serum Levels of Perfluoroalkyl Substances in Early Pregnancy and Offspring Birth Weight. Pediatr. Res. 2020, 87 (6), 1093–1099.
  94. Xie, X.; Weng, X.; Liu, S. Perfluoroalkyl and Polyfluoroalkyl Substance Exposure and Association with Sex Hormone Concentrations: Results from the NHANES 2015–2016. Environ. Sci. Eur. 2021, 33, 69. https://doi.org/10.1186/s12302-021-00508-9
  95. Xu, B.; Qiu, W.; Du, J.; Wan, Z.; Zhou, J. L.; Chen, H.; Liu, R.; Magnuson, J. T.; Zheng, C. Translocation, Bioaccumulation, and Distribution of Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs) in Plants. iScience 2022, 25 (4), 104061. https://doi.org/10.1016/j.isci.2022.104061
  96. Xu, Y.; Fletcher, T.; Pineda, D.; Lindh, C. H.; Nilsson, C.; Glynn, A. Serum Half-Lives for Short- and Long-Chain Perfluoroalkyl Acids after Ceasing Exposure from Drinking Water Contaminated by Firefighting Foam. Environ. Health Perspect. 2020, 128, 77004.
  97. Xuping, G.; Wanze, N.; Sui Zhu; Yanxin, W.; Yunfeng, C.; Junrong, M.; Yanhua, L.; Jinlong, Q.; Yanbin, Y.; Pan, Y.; Chaoqun, L.; Fangfang, Z. Per- and Polyfluoroalkyl Substances Exposure during Pregnancy and Adverse Pregnancy and Birth Outcomes: A Systematic Review and Meta-Analysis. Environ. Res. 2021, 201, 111632.
  98. Yang, M.; Lee, Y.; Gao, L.; Chiu, K.; Meling, D. D.; Flaws, J. A.; Warner, G. R. Perfluorooctanoic Acid Disrupts Ovarian Steroidogenesis and Folliculogenesis in Adult Mice. Toxicol. Sci. 2022, 186 (2), 260–268.
  99. Yao, P. L.; Ehresman, D. J.; Rae, J. M. C.; Chang, S. C.; Frame, S. R.; Butenhoff, J. L.; Kennedy, G. L.; Peters, J. M. Comparative in Vivo and in Vitro Analysis of Possible Estrogenic Effects of Perfluorooctanoic Acid. Toxicology 2014, 326, 62–73.
  100. Zeng, L. H.; Rana, S.; Hussain, L.; Asif, M.; Mehmood, M. H.; Imran, I.; Younas, A.; Mahdy, A.; Al-Joufi, F. A.; Abed, S. N. Polycystic Ovary Syndrome: A Disorder of Reproductive Age, Its Pathogenesis, and a Discussion on the Emerging Role of Herbal Remedies. Front. Pharmacol. 2022, 13, 874914. https://doi.org/10.3389/fphar.2022.874914
  101. Zhan, W.; Qiu, W.; Ao, Y.; Zhou, W.; Sun, Y.; Zhao, H.; Zhang, J. Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis. Environ. Health Perspect. 2023, 131 (5), 57001. https://doi.org/10.1289/EHP11814
  102. Zhang, S.; Tan, R.; Pan, R.; Xiong, J.; Tian, Y.; Wu, J. Association of Perfluoroalkyl and Polyfluoroalkyl Substances with Premature Ovarian Insufficiency in Chinese Women. J. Clin. Endocrinol. Metab. 2018, 103, 2543–2551.
  103. Zhang, W.; Cao, H.; Liang, Y. Plant Uptake and Soil Fractionation of Five Ether-PFAS in Plant-Soil Systems. Sci. Total Environ. 2021, 771, 144805. https://pubmed.ncbi.nlm.nih.gov/33529820/
  104. Zhang, Z.; Sarkar, D.; Biswas, J. K.; Datta, R. Biodegradation of Per- and Polyfluoroalkyl Substances (PFAS): A Review. Bioresource Technol. 2022, 344, 126223. https://doi.org/10.1016/j.biortech.2021.126223
  105. Zheng, Q.; Yan, W.; Gao, S.; Li, X. The Effect of PFAS Exposure on Glucolipid Metabolism in Children and Adolescents: A Meta-Analysis. Front. Endocrinol. 2024, 15. https://doi.org/10.3389/fendo.2024.1261008
  106. Zhou, W.; Zhang, L.; Tong, C.; Fang, F.; Zhao, S.; Tian, Y.; Tao, Y.; Zhang, J. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women. Environ. Health Perspect. 2017, 125 (6), 067012. https://doi.org/10.1289/EHP1203